Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
1
17%
Ph early_phase_1
2
33%
Ph phase_3
2
33%
Ph not_applicable
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
2(33.3%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Terminated1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (33.3%)
Phase 32 (33.3%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

terminated117%
completed467%
suspended117%

Recent Activity

0 active trials
Showing 5 of 6
terminatedearly_phase_1

Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?

NCT01954459
completedearly_phase_1

Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes

NCT01787318
completedphase_3

Pediatric Diabetics Type 1 Using InsuPatch

NCT01368978
completedphase_3

Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies

NCT01216618
completedphase_4

Evaluation of the Safety Use of the InsuPatch Device in Daily Life Conditions

NCT01283425
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01954459Early Phase 1

Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?

Terminated
NCT01787318Early Phase 1

Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes

Completed
NCT01368978Phase 3

Pediatric Diabetics Type 1 Using InsuPatch

Completed
NCT01216618Phase 3

Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies

Completed
NCT01283425Phase 4

Evaluation of the Safety Use of the InsuPatch Device in Daily Life Conditions

Completed
NCT01114061Not Applicable

Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the InsuPatch Device During Daily Life

Suspended

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6